Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

Dermatology Devices Market Size surpass US$ ~79.68 Billion By 2030, Predicts Growth Plus Reports

Published

on

Pune, Aug. 03, 2022 (GLOBE NEWSWIRE) — The global dermatology devices market is expected to clock US$ ~79.68 billion by 2030 owing rise in the prevalence of diseases requiring surgical treatment, particularly minimally invasive surgery, is expected to boost the dermatology devices market in the coming years.

Market Driver

The rising prevalence of skin disorders, which necessitates dermatological treatment, is expected to propel the market to higher revenue generation. The growing prevalence of conditions such as psoriasis, acne, and other skin disorders is expected to boost market revenue during the forecast period.

Technological advancements in dermatology, accompanied by regulatory approvals, have helped manufacturers capitalize on market opportunities and maintain their position. The development of novel therapies and devices to treat metastatic melanoma and malignant skin cancer etc. will drive the dermatology diagnostic devices market forward. Additionally, the introduction of digitalization within dermatology devices used for accurate diagnosis will allow for greater adoption of these devices in developed economies.

The global dermatology devices market has been analyzed from four perspectives: type, application, end user, and region.

Request a Sample Copy of the Research Report: https://growthplusreports.com/inquiry/request-sample/dermatology-devices-market/7737

Excerpts ‘By Diagnostic Device’

Based on type, the dermatology devices market is segmented into:

  • Diagnostic Devices
  • Treatment Devices

Diagnostis devices are sub segmented into imaging devices, dermatoscopes, and microscopes; whereas treatment devices are also sub segmented into electrosurgical, cryotherapy, and laser devices. Treatment devices dominated the global market during the forecast period, owing to the rising incidence of skin cancer due to UV radiation exposure as well as hazardous radiations in chemical industries should drive up demand for skincare devices. A surge in the demand for non-invasive treatments for skin cancers and other skin disorders will open up several new avenues for growth. Furthermore, device innovation, as well as access to advanced treatment devices for improved aesthetics, should drive product the demand. Furthermore, extensive use of liposuction and electrosurgical equipment will also drive up demand for skincare devices. These devices have remained valuable in the dermatology industry, with new technologies such as artificial intelligence (AI) enhancing their uses to make them an essential tool in every medical professional’s office. Furthermore, they are gaining traction in other areas of medicine, including primary care. Moreover, the introduction of advanced dermatoscopes is anticipated to drive product demand during the forecast period. For instance, in 2020, HEINE, a global primary diagnostic instrument manufacturer, launched two new dermatoscopes, DELTA 30 and DELTAone in the United States, each with an improved achromatic optical system for pristine images.

Excerpts ‘By Region Segmentation’

Based on regions, the global dermatology devices market has been segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

North America has reported the largest share of the market. Because of the rising prevalence of skin cancer and other skin diseases such as eczema and rosacea, and this trend is likely to continue in the future. Skin cancer cases are increasing globally. According to Skincare Foundation data, one in every five Americans will develop skin cancer by the age of 70. More than two people in the United States die from skin cancer every hour. Melanoma has a five year survival rate of 99 percent when detected early. As a result, the rising prevalence of skin cancer and other skin diseases will significantly contribute to the high demand for the dermatology devices market.

Several medical technology companies concentrate on developing products that provide less expensive, faster, and more efficient patient care. Lancer Skincare announced the availability of the first skincare exfoliating device, the Pro Polish Microdermabrasion Device in July 2020. Pro Polish boosts the efficacy of the Lancer routine by delivering surface-layer microdermabrasion in a patented, handheld device. These advancements in dermatology devices, in terms of features and broad application for skin diseases, are expected to boost market demand for dermatology devices.

In the near future, Asia Pacific is expected to grow at a significant rate in the market because of rising patient awareness, undiscovered opportunities, increasing penetration, and rapidly appealing healthcare infrastructure. Additionally, an increase in the number of international firms conducting research and development in the Asia Pacific is expected to boost the growth of dermatology devices market.

To read more about the latest highlights related to dermatology device, get a snapshot of the key highlights entailed in the global dermatology device market

Competitive Landscape

Some of the prominent players in the global dermatology devices market include:

  • Alma Lasers GmbH
  • Cynosure, Inc
  • Solta Medical, Inc
  • Cutera, Inc
  • Bruker Corporation
  • Syneron Medical Ltd
  • Canfield Scientific, Inc
  • Carl Zeiss
  • Candela Corporation
  • HEINE Optotechnik GmbH & Co. KG
  • Lumenis, Ltd
  • Bovie Medical Corporation
  • Among others

Report Scope & Segmentation:

Report Coverage Details
Market Size in 2021 USD ~ 54.08 billion
Revenue forecast in 2030 USD ~ 79.68 billion
Growth Rate CAGR of ~4.4% from 2022 to 2030
Base year for estimation 2021
Forecast period 2022-2030
Segments covered Type, Application, End User
Regional scope North America, Europe, Asia Pacific, and the Rest of the World (ROW)

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Request for customization of this research report at: https://growthplusreports.com/inquiry/customization/dermatology-devices-market/7737

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

TRON Forum collaborates with four major microcontroller manufacturers to hold TRON Programming Contest Using World-Standard Real-Time OS with 5 million JP YEN cash prize

Published

on

tron-forum-collaborates-with-four-major-microcontroller-manufacturers-to-hold-tron-programming-contest-using-world-standard-real-time-os-with-5-million-jp-yen-cash-prize

TOKYO, March 29, 2024 /PRNewswire/ — TRON Forum (Chair: Ken Sakamura, Professor Emeritus of the University of Tokyo) is pleased to announce that four microcontroller manufacturers, Infineon Technologies Japan K.K. (President & CEO: Ikuya Kawasaki), STMicroelectronics K.K. (Country Manager for Japan: Koichiro Takakuwa), NXP Japan K.K. (President & CEO: Masayuki Wajima), and Renesas Electronics Corporation (President & CEO: Hidetoshi Shibata) have collaborated with the Forum to hold TRON Programming Contest from Monday, December 11, 2023 jointly. The initial registration is being accepted now.

This contest is for engineers and students in Japan and overseas to compete in various  fields such as microcontroller applications, middleware, development environments, and tools using a member of TRON real-time OS (RTOS) family, “μT-Kernel 3.0” (*), which is a global standard of small-scale embedded computer systems.
(*) μT-Kernel 3.0 is an RTOS that fully complies with the real-time OS standard “IEEE 2050-2018” (IEEE Standard for a Real-Time Operating System (RTOS) for Small-Scale Embedded Systems) and runs on microcontrollers from various manufacturers.
Using the latest microcomputer boards provided by the manufacturers, contestants will compete in technologies that bring out the characteristics of RTOSs such as real-time performance, power saving, and small memory footprint, as well as development environments and tools that utilize new technologies.
The details of the contest with the total amount of cash prize, five million Japanese yen are at the following URL: https://www.tron.org/programming_contest/
About TRON Forum
TRON Forum was established in 2002 to promote TRON Project. We have been actively conducting activities centered on the T-Engine project, which prepares the development environment for embedded systems, and the operation of Ubiquitous ID Centers such as ucode.
In May 2015, Chair Sakamura received the ITU 150th Anniversary Award together with Bill Gates and others for his advocacy of open architecture TRON, which is the origin of ubiquitous networking and the IoT.
One member of the TRON RTOS family has been adopted as an international standard for real-time operating systems (RTOS) for small-scale embedded systems as 2050-2018 by Institute of Electrical and Electronics Engineers (IEEE), the world’s largest association of its kind and an international standardization organization. In 2023, the project leader, Chair Sakamura, received the IEEE Masaru Ibuka Consumer Technology Award from the IEEE in honor of the late Mr. Ibuka. In addition, the TRON RTOS family received the IEEE Milestone recognition in 2023.
URL: https://www.tron.org 
 
 

View original content:https://www.prnewswire.co.uk/news-releases/tron-forum-collaborates-with-four-major-microcontroller-manufacturers-to-hold-tron-programming-contest-using-world-standard-real-time-os-with-5-million-jp-yen-cash-prize-302103284.html

Continue Reading

Artificial Intelligence

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Published

on

xtalpi-unveils-xtalgazer:-a-comprehensive-ai-driven-polymorph-selection-platform

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html

Continue Reading

Artificial Intelligence

ICIS and Base Oil News Announce Partnership to Enhance Market Insights

Published

on

icis-and-base-oil-news-announce-partnership-to-enhance-market-insights

LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.

With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.  
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html

Continue Reading
Advertisement

Latest News

Trending